Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | ENPP3 | O14638 | 3/20 | 0.55 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9852204 | 1.00 | MEN1 (0.60) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL18179825 | 1.00 | MEN1 (0.60) | MEN1KMT2ACA2CA1CA9 | |
| Iodide SCHEMBL22068772 | 0.98 | CA2 (0.59) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL6937173 | 0.94 | CA2 (0.64) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL941647 | 0.94 | GAA (0.64) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL13924689 | 0.92 | ALDH1A1 (0.55) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL10413156 | 0.92 | HTT (0.60) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL2066187 | 0.92 | MEN1 (0.54) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL8069392 | 0.92 | MEN1 (0.54) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL6938753 | 0.92 | HTT (0.60) | MEN1KMT2ACA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023137146-A9 | CELLULOSE ESTER COMPOSITION AND PROCESS FOR PRODUCING ARTICLES THEREFROM | CELANESE INTERNATIONAL CORPORATION (US) | 2024-05-23 | — | — | WO | claimed |
| WO-2023137146-A1 | CELLULOSE ESTER COMPOSITION AND PROCESS FOR PRODUCING ARTICLES THEREFROM | CELANESE INTERNATIONAL CORPORATION (US) | 2023-07-20 | — | — | WO | claimed |
| US-12570769-B2 | Paramylon-based resin, molding material, molded body, and production method for paramylon-based resin | NEC CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20260055132-A1 | TLR7 AGONISTS | PRIMMUNE THERAPEUTICS INC (US) | 2026-02-26 | — | — | US | disclosed |
| US-20260047987-A1 | BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR | DAICEL CORPORATION (JP) | 2026-02-19 | — | — | US | disclosed |
| US-12522671-B2 | Paramylon-based resin, molding material, molded body, and method for producing paramylon-based resin | NEC CORPORATION (JP) | 2026-01-13 | — | — | US | disclosed |
| US-20250250364-A1 | PARAMYLON-BASED RESIN AND PRODUCING METHOD THEREOF, MOLDING RESIN COMPOSITION, AND MOLDED BODY | NEC CORPORATION (JP) | 2025-08-07 | — | — | US | disclosed |
| US-20250188028-A1 | Synthetic Method for Producing Ionizable Amino Lipids | NANOVATION THERAPEUTICS INC. (CA) | 2025-06-12 | — | — | US | disclosed |
| US-20250129077-A1 | SUBSTITUTED PURINES AS TLR7 AGONISTS | Primmune Therapeutics, Inc. | 2025-04-24 | — | — | US | disclosed |
| WO-2025053227-A1 | POLYSACCHARIDE-BASED BIOMASS PLASTIC, RESIN COMPOSITION FOR MOLDING USING SAME, AND MOLDED BODY | 日本電気株式会社 | 2025-03-13 | — | — | WO | disclosed |
| US-20250073134-A1 | BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR | DAICEL CORPORATION (JP) | 2025-03-06 | — | — | US | disclosed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| US-6369265-B1 | HETEROCOUPLING REACTION, MIXING IN A LIQUID AN ARYL HALIDE, BONDING TO AROMATIC RINGS, GRIGNARD REACTION, METAL COMPOUND AND HETEROCYCLIC CARBENE | UNIVERSITY OF NEW ORLEANS RESEARCH & TECHNOLOGY FOUNDATION | 2002-04-09 | — | — | US | disclosed |
| US-6365776-B1 | FROM ORGANOHALOGEN COMPOUND AND AMINE USING PALLADIUM COMPOUND CATALYST AND PROMOTER | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-04-02 | — | — | US | disclosed |
| US-20020035295-A1 | PROCESS FOR PRODUCING AROMATIC AMINES | TAKASAGO INTERNATIONAL CORPORATION | 2002-03-21 | — | — | US | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
| US-6072073-A | REACTING COMPOUND HAVING CARBONYL GROUP WITH ARYLATING OR VINYLATING COMPOUND IN PRESENCE OF BASE AND TRANSITION METAL CATALYST | YALE UNIVERSITY (US) | 2000-06-06 | — | — | US | disclosed |
| WO-1999011863-A1 | METHOD OF MAKING PAPER | EASTMAN CHEMICAL COMPANY (US) | 1999-03-11 | — | — | WO | disclosed |
| EP-0813626-A1 | FIBROUS WEB HAVING IMPROVED STRENGTH AND METHOD OF MAKING THE SAME | WEYERHAEUSER COMPANY (US) | 1997-12-29 | — | — | EP | disclosed |
| WO-1996027703-A1 | FIBROUS WEB HAVING IMPROVED STRENGTH AND METHOD OF MAKING THE SAME | WEYERHAEUSER COMPANY (US) | 1996-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035295-A1 | PROCESS FOR PRODUCING AROMATIC AMINES | TYR, DDC, PNMT | MEN1 1606/4885KMT2A 359/4885CA2 3856/4885 |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | DDT, PDCD11, PLD2 | MEN1 2881/4885KMT2A 170/4885CA2 3780/4885 |
| US-20260047987-A1 | BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR | PGA5, CD68, SBDS | MEN1 3889/4885KMT2A 3786/4885CA2 2959/4885 |
| US-12570769-B2 | Paramylon-based resin, molding material, molded body, and production method for paramylon-based resin | MSL1, HACD2, RRS1 | MEN1 1153/4885KMT2A 1419/4885CA2 4408/4885 |
| US-20250188028-A1 | Synthetic Method for Producing Ionizable Amino Lipids | FASN, BCAT1, ASNS | MEN1 870/4885KMT2A 1613/4885CA2 1307/4885 |
| US-20260055132-A1 | TLR7 AGONISTS | TLR7, TLR8, TLR1 | MEN1 4207/4885KMT2A 1143/4885CA2 3063/4885 |
| US-20250129077-A1 | SUBSTITUTED PURINES AS TLR7 AGONISTS | TLR7, TLR9, TLR1 | MEN1 4315/4885KMT2A 2261/4885CA2 4772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.